OVERVIEW
INVESTOR.HTGC.COM RANKINGS
Date Range
Date Range
Date Range
LINKS TO WEB PAGE
Hercules Capital is the largest business development company focused on venture lending, and the lender of choice for innovative entrepreneurs and their venture capital partners. Co-investments with VC and PE firms. New debt and equity commitments. Co-investments with VC and PE firms. New debt and equity commitments. Since inception through Q4 2017. is a clinical-stage biopharmaceutical company.
WHAT DOES INVESTOR.HTGC.COM LOOK LIKE?
INVESTOR.HTGC.COM HOST
FAVORITE ICON
SERVER OPERATING SYSTEM AND ENCODING
I diagnosed that this website is implementing the Microsoft-IIS/8.5 operating system.TITLE
Overview Hercules CapitalDESCRIPTION
The Investor Relations website contains information about Hercules Technology Growth Capital business for stockholders, potential investors, and financial analysts.CONTENT
This website investor.htgc.com had the following on the homepage, "Venture Debt Financing Sets the Stage for Insmed to Seize Strategic Opportunity." Our analyzers viewed that the website said " Hercules Highly Asset Sensitive Debt Investment Portfolio to Generate Additional 0." The Website also said "04 of Net Investment Income Earnings Annually2 from the Recent Increase in the Federal Reserve Benchmark Interest Rate. Latest Quarterly Earnings Q4 2017 - Thursday, Feb 22, 2018."SUBSEQUENT WEBSITES
There are currently no events to display.
Strategy, Policy Analysis, Regulatory Development. ICF in Africa the Middle East. ICF in Asia the Pacific. ICF is fluent in the language of change, whether driven by markets, technology, or policy.
Lower-cost transactional solutions with strategic resourcing and innovative technologies. Integrated services that cover planning, management, execution and analysis. Insight on strategies and execution for long-term value to maximise success. Global experience in all Phases of oncology drug development. Offering solutions that combine in-house expertise and proprietary innovative technology. 2 - 5 April, 2018.
Illumina Accelerator Invests in Second Class of Genomics Startups from US and Europe. Illumina Signs Agreement to Acquire GenoLogics, Leader in Genomics Laboratory Information Management System Market. Illumina Reports Financial Results for Second Quarter of Fiscal Year 2015. Illumina Names Sanjay Chikarmane as Senior Vice President and General Manager of Enterprise Informatics. Q2 2015 Illumina, Inc.
Vision, Mission and Values. Our mission is to ensure that patients in need of blood, organs, or stem cells get the right match that is safe, accessible, and affordable. Avi Pelossof Appointed President and CEO of Immucor.